AN2 Therapeutics to Present at Jefferies Global Healthcare Conference in London
Business Wire•04/11/2026•16:00 ET
0
Key Highlights
- ➤AN2 Therapeutics will present at Jefferies Global Healthcare Conference on November 16, 2026
- ➤Eric Easom will present; management will hold one-on-one investor meetings
- ➤Pipeline includes three Phase 2 studies expected active in 2026
- ➤Pipeline includes two preclinical oncology candidates and advanced research programs
Expert Statements
Eric Easom, Co-Founder, Chairman, President and CEO of AN2 Therapeutics
“members of management will be available for 1x1 meetings”
AN2 Therapeutics to Present at Jefferies Global Healthcare Conference in London
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026 at 9:30 am GMT and members of management will be available for 1x1 meetings.
Get started
Create a free account to read the full story.